Qinlock (ripretinib)

pCPA File Number: 21850
Negotiation Status:
Under consideration for negotiation
Indication(s):
For the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with imatinib, sunitinib, and regorafenib
Sponsor/Manufacturer:
Medison Pharma Canada Inc.
CADTH Project Number:
PC0265-
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable